2025-04-01 2026-03-31 false Capium Accounts Production 1.1 12526871 2025-04-01 2026-03-31 12526871 bus:AbridgedAccounts 2025-04-01 2026-03-31 12526871 bus:FRS102 2025-04-01 2026-03-31 12526871 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 12526871 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 12526871 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 12526871 2025-04-01 2026-03-31 12526871 2026-03-31 12526871 bus:RegisteredOffice 2025-04-01 2026-03-31 12526871 core:WithinOneYear 2026-03-31 12526871 core:AfterOneYear 2026-03-31 12526871 1 2025-04-01 2026-03-31 12526871 bus:Director1 2025-04-01 2026-03-31 12526871 bus:Director1 2026-03-31 12526871 bus:Director1 2024-04-01 2025-03-31 12526871 2024-04-01 12526871 bus:LeadAgentIfApplicable 2025-04-01 2026-03-31 12526871 2024-04-01 2025-03-31 12526871 2025-03-31 12526871 core:WithinOneYear 2025-03-31 12526871 core:AfterOneYear 2025-03-31 12526871 bus:EntityAccountantsOrAuditors 2024-04-01 2025-03-31 12526871 core:PlantMachinery 2025-04-01 2026-03-31 12526871 core:PlantMachinery 2026-03-31 12526871 core:PlantMachinery 2025-03-31 12526871 core:FurnitureFittings 2025-04-01 2026-03-31 12526871 core:FurnitureFittings 2026-03-31 12526871 core:FurnitureFittings 2025-03-31 12526871 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2026-03-31 12526871 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-03-31 12526871 core:NetGoodwill 2025-04-01 2026-03-31 12526871 core:NetGoodwill 2026-03-31 12526871 core:NetGoodwill 2025-03-31 12526871 core:CostValuation core:Non-currentFinancialInstruments 2026-03-31 12526871 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 12526871 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-03-31 12526871 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 12526871 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 12526871 core:Non-currentFinancialInstruments 2026-03-31 12526871 core:Non-currentFinancialInstruments 2025-03-31 12526871 core:RevaluationReserve 2026-03-31 12526871 core:RevaluationReserve 2025-03-31 12526871 core:RetainedEarningsAccumulatedLosses 2026-03-31 12526871 core:RetainedEarningsAccumulatedLosses 2025-03-31 12526871 dpl:Item1 2025-04-01 12526871 dpl:Item1 2026-03-31 12526871 dpl:Item1 2024-04-01 12526871 dpl:Item1 2025-03-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 12526871
England and Wales
THE ABBEY CLINIC (NOTTINGHAM) LIMITED
Abridged Accounts
Period of accounts Start date: 01 April 2025 End date: 31 March 2026

THE ABBEY CLINIC (NOTTINGHAM) LIMITED Contents Page For the year ended 31 March 2026
Accountants' report | 1
Statement of financial position | 2
Notes to the financial statements | 3

THE ABBEY CLINIC (NOTTINGHAM) LIMITED Accountants' Report For the year ended 31 March 2026
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of THE ABBEY CLINIC (NOTTINGHAM) LIMITED for the year ended 31 March 2026 which comprise of the Profit and Loss Account, the Balance Sheet and the related notes from the companys accounting records and from information and explanations you have given us. As a practising member firm of the Institute of Chartered Accountants in England and Wales, we are subject to its ethical and other professional requirements which are detailed at www.icaew.com/en/members/regulations-standards-and-guidance. This report is made solely to the Board of Directors of THE ABBEY CLINIC (NOTTINGHAM) LIMITED , as a body, in accordance with the terms of our engagement letter dated . Our work has been undertaken solely to prepare for your approval the accounts of THE ABBEY CLINIC (NOTTINGHAM) LIMITED and state those matters that we have agreed to state to the Board of Directors of THE ABBEY CLINIC (NOTTINGHAM) LIMITED , as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than THE ABBEY CLINIC (NOTTINGHAM) LIMITED and its Board of Directors as a body for our work or for this report. It is your duty to ensure that THE ABBEY CLINIC (NOTTINGHAM) LIMITED has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of THE ABBEY CLINIC (NOTTINGHAM) LIMITED . You consider that THE ABBEY CLINIC (NOTTINGHAM) LIMITED is exempt from the statutory audit requirement for the year. We have not been instructed to carry out an audit or a review of the accounts of THE ABBEY CLINIC (NOTTINGHAM) LIMITED . For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts. .................................................... M Ahmed & Co Accountants Ltd Chartered Accountants 83 Park Road Nottingham NG9 4DE 22 May 2026 1

THE ABBEY CLINIC (NOTTINGHAM) LIMITED Statement of Financial Position As at 31 March 2026
| Notes | 2026 £ |  | 2025 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Intangible fixed assets | 3 | 28,000 |  | 30,000
Tangible fixed assets | 4 | 19,089 |  | 22,458
|  | 47,089 |  | 52,458
Current assets |  |  |
Stocks |  | 3,533 |  | 3,533
Cash at bank and in hand |  | 7,669 |  | 8,881
|  | 11,202 |  | 12,414
Creditors: amount falling due within one year |  | (48,748) |  | (54,279)
Net current assets |  | (37,546) |  | (41,865)
Total assets less current liabilities |  | 9,543 |  | 10,593
Creditors: amount falling due after more than one year |  | 0 |  | (1,669)
Net assets |  | 9,543 |  | 8,924
Capital and reserves |  |  |
Revaluation Reserves |  | 100 |  | 100
Profit and loss account |  | 9,443 |  | 8,824
Shareholders' funds |  | 9,543 |  | 8,924
For the year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006 the profit and loss account has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the director on 22 May 2026 and were signed by:
------------------------------- Siamak TAYMOURI Director
2

THE ABBEY CLINIC (NOTTINGHAM) LIMITED Notes to the Abridged Financial Statements For the year ended 31 March 2026
General Information THE ABBEY CLINIC (NOTTINGHAM) LIMITED is a private company, limited by shares, registered in England and Wales, registration number 12526871, registration address 6 Ludgate Close, Nottingham, NG5 9QQ.
1. | Accounting policies Significant accounting policies The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard) Turnover Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, Value Added Tax and other sales taxes. Taxation Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Current and deferred tax assets and liabilities are not discounted Intangible assets Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. Goodwill Acquired goodwill is stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the goodwill of 20 years. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery | 15% Reducing Balance
Fixtures and Fittings | 15% Reducing Balance
Stocks Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items.
2. | Average number of employees Average number of employees during the year was 3 (2025 : 2).
3. | Intangible fixed assets
Cost | Goodwill |  | Total
| £ |  | £
At 01 April 2025 | 40,000 |  | 40,000
Additions | - |  | -
Disposals | - |  | -
At 31 March 2026 | 40,000 |  | 40,000
Amortisation
At 01 April 2025 | 10,000 |  | 10,000
Charge for year | 2,000 |  | 2,000
On disposals | - |  | -
At 31 March 2026 | 12,000 |  | 12,000
Net book values
At 31 March 2026 | 28,000 |  | 28,000
At 31 March 2025 | 30,000 |  | 30,000
4. | Tangible fixed assets
Cost or valuation | Plant and Machinery |  | Fixtures and Fittings |  | Total
| £ |  | £ |  | £
At 01 April 2025 | 42,614 |  | 2,917 |  | 45,531
Additions | - |  | - |  | -
Disposals | - |  | - |  | -
At 31 March 2026 | 42,614 |  | 2,917 |  | 45,531
Depreciation
At 01 April 2025 | 21,904 |  | 1,169 |  | 23,073
Charge for year | 3,107 |  | 262 |  | 3,369
On disposals | - |  | - |  | -
At 31 March 2026 | 25,011 |  | 1,431 |  | 26,442
Net book values
Closing balance as at 31 March 2026 | 17,603 |  | 1,486 |  | 19,089
Opening balance as at 01 April 2025 | 20,710 |  | 1,748 |  | 22,458
3